Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Atherosclerosis

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0021-9150(97)00209-8PMID 9543092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons.

  1996cited by this paper
• Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin.

  1995cited by this paper
• Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.

  1995cited by this paper
• Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina.

  1995cited by this paper
• Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina.

  1995cited by this paper
• Low serum apolipoprotein A-I level in patients with vasospastic angina.

  1993cited by this paper
• Cigarette Smoking Is a Major Risk Factor for Coronary Spasm

  1993cited by this paper
• Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels.

  1993cited by this paper
• Plasma Lipoproteins and Progression of Coronary Artery Disease Evaluated by Angiography and Clinical Events

  1993cited by this paper
• Clinical characteristics of patients with spontaneous remission of variant angina.

  1993cited by this paper
• Automated immunoturbidimetric analysis of six plasma apolipoproteins: Correlation with radial immunodiffusion assays

  1991cited by this paper
• Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis.

  1990cited by this paper
• Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.

  1990cited by this paper
• Comparison of serum lipid values in variant angina pectoris and fixed coronary artery disease with normal subjects.

  1989cited by this paper
• Long-term prognosis for patients with variant angina and influential factors.

  1988cited by this paper
• Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

  1988cited by this paper
• Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina.

  1987cited by this paper
• The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.

  1987cited by this paper
• Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.

  1987cited by this paper
• Atherosclerosis and lipoprotein metabolism: role of reverse cholesterol transport.

  1986cited by this paper
• Comparison of risk factors in vasospastic angina without significant fixed coronary narrowing to significant fixed coronary narrowing and no vasospastic angina.

  1986cited by this paper
• Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography.

  1984cited by this paper
• Hypertriglyceridaemia and hypercoagulability.

  1983cited by this paper
• Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.

  1983cited by this paper
• Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.

  1982cited by this paper
• Update on the role of cigarette smoking in coronary artery disease.

  1981cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Protective Impact of Vanillic Acid on Lipid Profile and Lipid Metabolic Enzymes in Diabetic Hypertensive Rat Model Generated by A High-Fat Diet.

  2023cites this paper
• Differential diagnostic factors of type 1 and type 2 myocardial infarction in patients with elevated cardiac troponin levels

  2020influential citation
• Effet anti-inflammatoire et anti obésité des extraits polyphénoliques de feuilles de caroube "Ceratonia siliqua" et cladode de figuier de barbarie "Opuntia ficus-indica"

  2018cites this paper
• Effects of PUFA on lipid level in patients with diabetes : Hospital based study

  2016cites this paper
• Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.

  2014cites this paper
• Remnant Lipoproteins: A Subfraction of Plasma Triglyceride-Rich Lipoproteins Associated with Postprandial Hyperlipidemia

  2014cites this paper
• Omega (n- 3) Polyunsaturated Fatty Acids and Diabetic Patients

  2014cites this paper
• Association of dyslipidemia with vasospastic angina.

  2014cites this paper
• Remnant cholesterol as a causal risk factor for ischemic heart disease.

  2013cites this paper
• Dyslipidemia in Obesity: Mechanisms and Potential Targets

  2013cites this paper
• Recent Advances in Cardiovascular Risk Factors

  2012cites this paper
• Remnant Lipoproteins are a Stronger Risk Factor for Cardiovascular Events than LDL-C - From the Studies of Autopsies in Sudden Cardiac Death Cases

  2012cites this paper
• Lipids, Atherogenic Dyslipidemia, and Therapy

  2012cites this paper
• Effects of olive oil on lipid profiles and blood glucose in type2 diabetic patients

  2011cites this paper
• Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases.

  2008cites this paper
• Polimorfismo da apolipoproteína C-III (APOC-III) e níveis de triacilgliceróis em japoneses residentes no sul do Brasil

  2007cites this paper
• Metabolism of diacylglycerol in humans.

  2007cites this paper
• High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.

  2007cites this paper
• ApoB-100 carrying lipoprotein, but not apoB-48, is the major subset of proatherogenic remnant-like lipoprotein particles detected in plasma of sudden cardiac death cases.

  2007cites this paper
• Association of remnant-like lipoprotein particles cholesterol with "oketsu" syndrome

  2006cites this paper
• Postprandial lipaemia in menopausal women with metabolic syndrome.

  2006cites this paper
• Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese.

  2006cites this paper
• The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.

  2006cites this paper
• Clinical relevance of postprandial lipaemia.

  2005cites this paper
• Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance.

  2005cites this paper
• Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes

  2005cites this paper
• Remnant lipoproteins and atherosclerosis

  2005cites this paper
• Effects of cilostazol on lipid and fatty acid metabolism

  2005cites this paper
• Serum amyloid A, C-reactive protein and remnant-like lipoprotein particle cholesterol in type 2 diabetic patients with coronary heart disease

  2004cites this paper
• Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype

  2004cites this paper
• Remnant Lipoproteins from Patients with Sudden Cardiac Death Enhance Coronary Vasospastic Activity Through Upregulation of Rho-Kinase

  2004cites this paper
• The close relationship between postprandial remnant metabolism and insulin resistance.

  2004cites this paper
• High remnant lipoprotein levels in patients with variant angina

  2004cites this paper
• Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death.

  2004cites this paper
• Remnant Lipoprotein Particles Induce Apoptosis in Endothelial Cells by NAD(P)H Oxidase–Mediated Production of Superoxide and Cytokines via Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Activation: Prevention by Cilostazol

  2004cites this paper
• Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease

  2003cites this paper
• Effects of treatment with Sandostatin® LAR® on small dense LDL and remnant‐like lipoproteins in patients with acromegaly

  2003cites this paper
• Biochemical markers of vasospastic coronary artery disease.

  2003cites this paper
• Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.

  2003cites this paper
• Possible Relationship between Insulin Resistance and Remnant‐Like Lipoprotein Particles in Coronary Endothelial Dysfunction

  2002cites this paper
• Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction.

  2002cites this paper
• Recomendaciones del NCEP-ATPIII. Dislipemia aterogénica y redefinición de valores deseables de triglicéridos

  2002cites this paper
• Remnant-like lipoprotein particles in type 2 diabetic patients with apolipoprotein E3/3 and apolipoprotein E2 genotypes.

  2002cites this paper
• Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia.

  2002cites this paper
• Atherogenic lipoproteins and diabetes mellitus.

  2002cites this paper
• Acute effect of orlistat on post‐prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus

  2002cites this paper
• Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men.

  2002cites this paper
• Effects of soy protein on levels of remnant-like particles cholesterol and vitamin E in healthy men.

  2001cites this paper
• Obesity and free fatty acids: double trouble.

  2001cites this paper
• Clinical significance of preheparin serum lipoprotein lipase mass in coronary vasospasm.

  2001cites this paper
• Impaired glucose tolerance without hypertriglyceridemia does not enhance postprandial lipemia.

  2001cites this paper
• Elevated apolipoprotein B‐48 and remnant‐like particle–cholesterol in heterozygous familial hypercholesterolaemia

  2001cites this paper
• Impaired Glucose Tolerance Without Hypertriglyceridemia Does not Enhance Postprandial Lipemia

  2001cites this paper
• Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

  2001cites this paper
• Plasma triglyceride-rich lipoprotein remnants as a risk factor of 'Pokkuri disease'.

  2001cites this paper
• Triglycerides and atherosclerosis: to feast or fast.

  2000cites this paper
• Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.

  2000cites this paper
• INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING TREATMENT OF HYPERTENSION WITH CILNIDIPINE.

  2000cites this paper
• Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease.

  2000cites this paper
• Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.

  2000cites this paper
• Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

  2000cites this paper
• INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING AMLODIPINE TREATMENT OF HYPERTENSION IN JAPANESE PATIENTS.

  2000cites this paper
• Triglycerides and atherosclerosis: to feast or fast.

  2000cites this paper
• Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.

  2000cites this paper
• The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women.

  2000cites this paper
• Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.

  2000cites this paper
• Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.

  2000cites this paper
• Remnant-Like Particle Cholesterol Levels in Korean Patients with Coronary Artery Disease and Non-Insulin Dependent Diabetes Mellitus

  2000cites this paper
• Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet.

  2000cites this paper
• Association between triglyceride-rich lipoprotein remnant receptor polymorphisms and lipid traits.

  2000cites this paper
• The Significance of Atherogenic Indices in Patients on Hemodialysis

  2000cites this paper
• The atherogenic lipoprotein phenotype in renal disease

  1999cites this paper
• Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients.

  1999cites this paper
• Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia

  1999cites this paper
• Lipoprotein(a), homocysteine, and remnantlike particles: emerging risk factors.

  1999cites this paper
• Hyperlipidaemia and cardiovascular disease.

  1998cites this paper
• Remnant-like particle cholesterol in coronary artery disease: correlation with plasminogen activator inhibitor-1 activity

  1998cites this paper
• Hyperlipidaemia and cardiovascular disease.

  1997cites this paper